3-Bromo-2-fluorophenylmethanol

We are 3-Bromo-2-fluorophenylmethanol CAS:261723-32-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3-Bromo-2-fluorophenylmethanol
Other Name:
3-Bromo-2-fluorophenylmethanol
(3-Bromo-2-fluorophenyl)methanol
3-Bromo-2-fluorobenzyl alcohol
Bromofluorophenylmethanol
3-bromo-2-fluoro Benzenemethanol
CAS No: 261723-32-4
MF: C7H6BrFO
MW: 205.02400
Density: 1.658g/cm3
Boiling point: 263.232ºC at 760 mmHg
Melting point: NA
Flash point: 112.999ºC
Refractive index: 1.567
UN Number: UN2811
UN Proper Shipping Name: ADR/RID: TOXIC SOLID, ORGANIC, N.O.S.
Transport hazard class: 6.1
Packing group: III
 
Specification
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Organic synthesis intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Bromo-2-fluorophenylmethanol


Related News: Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.267243-68-5 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.2-metoxi-3-nitropiridina CAS:20265-35-4 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.5- (Difluorometoxi) -2-mercapto-1H-bencimidazol CAS:97963-62-7 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.

Related Products
Product Name
Ethyl 2-(triphenylphosphoranylidene)propionate View Details
[dimethylamino-(2-oxopyridin-1-yl)oxymethylidene]-dimethylazanium,hexafluorophosphate View Details
1,3,5-Trimethylpiperidine View Details
Acetyl Dipeptide-1 Cetyl Ester manufacturer L-Cyclohexylglycine manufacturer 5-Benzyl L-glutamate N-carboxyanhydride manufacturer 3-(4-Methyl-1H-Imidazol-1-yl)-5-(Trifluoromethyl)Aniline manufacturer N-Benzoylcytidine manufacturer